---
title: Top Growth Opportunities in RNA Therapeutics
description: From targeting previously untreatable genes to developing smarter delivery systems, RNA innovation is redefining precision medicine, therapeutic reach, and market growth
image: https://go.frost.com/hubfs/Images/2025/TechVision/GO/DB32/D01_TV%20TGP%20H_W%20DB23_101325_VJ_3.jpg
---

### Top Growth Opportunities in RNA Therapeutics

From targeting previously untreatable genes to developing smarter delivery systems, RNA innovation is redefining precision medicine, therapeutic reach, and market growth.

Frost & Sullivan’s latest analysis explores the fastest-growing RNA modalities, delivery breakthroughs, and strategic investment trends shaping the future of genetic medicine.

***Will your strategy lead the next wave of transformation in RNA therapeutics?***

[**Download the Whitepaper**](https://go.frost.com/tgp/tv/rnatherapeuticshnw_nov25#form)

![RNA Therapeutics](https://go.frost.com/hs-fs/hubfs/Images/2025/TechVision/GO/DB32/DB32%20-%20RNA.jpg?width=532&height=266&name=DB32%20-%20RNA.jpg)

![head](https://f.hubspotusercontent20.net/hub/275827/hubfs/sr-assets/images/target.png?width=64&height=64&name=target.png)

## Disruptive Technologies

Next-generation RNA modalities — Self-amplifying RNA (saRNA), circular RNA (circRNA), small-activating RNA (RNAa), microRNA (miRNA), aptamers — are unlocking targets beyond the reach of small molecules and biologics.

![head](https://f.hubspotusercontent20.net/hub/275827/hubfs/sr-assets/images/presentation-1.png?width=64&height=64&name=presentation-1.png)

## Innovative Business Models

Partnership-driven approaches, licensing, and M&A are accelerating R&D, commercialization, and market expansion.

![head](https://f.hubspotusercontent20.net/hub/275827/hubfs/sr-assets/images/head.png?width=64&height=64&name=head.png)

## Rising Competitive Intensity

Tier I biopharma players are entering RNA through high-value alliances and acquisitions, raising the stakes for early innovators.

**What’s Inside?**

- **Expanding RNA Modalities:** How saRNA, circRNA, RNAa, miRNA, and aptamers are opening new therapeutic frontiers.
- **Breakthrough Delivery Systems: **Platforms like xPhore nanoparticles and Centyrins engineered proteins enabling extrahepatic targeting.
- **Funding & Partnerships: **Over 98% private capital and ~15 billion USD in strategic deal flow powering innovation.
- **Companies to Action: **Profiles of leaders such as Arrowhead Pharmaceuticals, Novartis, Vico Therapeutics, Altamira, and Aro Biotherapeutics.
- **Future Growth Potential: **A USD 500 millon to 1 billion market opportunity emerging over the next five years across North America, Europe, and Asia-Pacific.

Fill in the form to access your exclusive copy now.

##### Explore RNA Growth Opportunities

### Unlocking Growth in RNA Therapeutics

RNA Modalities and Delivery Technologies Reshaping Genetic Medicine

[Download Now](https://go.frost.com/tgp/tv/rnatherapeuticshnw_nov25#form)

![RNA Therapeutics](https://go.frost.com/hs-fs/hubfs/Images/2025/TechVision/GO/DB32/TGP_TV_HW_DB32_Whitepaper_Page_01.jpg?height=2000&name=TGP_TV_HW_DB32_Whitepaper_Page_01.jpg)

### Sign up for a complimentary Growth Pipeline Dialog™

A Growth Pipeline Dialog is a structured discussion with our growth experts providing unparalleled technology intelligence and proven implementation best practices. This discussion will spark innovative thinking and help generate a pipeline of growth opportunities you can leverage to maximize your company’s future growth potential.

Upon completing the dialog session, you will receive a $1,000 honorarium* as a token of our appreciation, which can be used towards the purchase of our products and services on [store.frost.com](https://store.frost.com?utm_source=hslinks).

[ Talk to our experts today! ](https://insights.frost.com/gpdialog?hsCtaTracking=2540db65-be35-44dd-abb4-f667210b0fde%7C973ed019-8950-4e26-8c86-4b58d2df9b85&hsLang=en)

*$1,000 honorarium is subject to eligibility

![drive-growth-image-scaled-2](https://go.frost.com/hs-fs/hubfs/drive-growth-image-scaled-2.webp?width=450&height=300&name=drive-growth-image-scaled-2.webp "drive-growth-image-scaled-2")